We are live on ! Find out more
COLL icon

Collegium Pharmaceutical
COLL

88 hedge funds and large institutions have $363M invested in Collegium Pharmaceutical in 2016 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 45 increasing their positions, 8 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

567% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 3

463% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 8

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

81.46% more ownership

Funds ownership: 0% → 81.46% (+81%)

24% more funds holding

Funds holding: 71 → 88 (+17)

19% more capital invested

Capital invested by funds: $305M → $363M (+$58M)

69% less call options, than puts

Call options by funds: $238K | Put options by funds: $779K

Holders
88
Holders Change
+17
Holders Change %
+23.94%
% of All Funds
2.2%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
20
Increased
45
Reduced
8
Closed
3
Calls
$238K
Puts
$779K
Net Calls
-$541K
Net Calls Change
+$364K

Top Buyers

1
SAM
Sectoral Asset Management
Quebec, Canada
+$23.2M
2
PHS
PFM Health Sciences
California
+$16.9M
3
Franklin Resources
Franklin Resources
California
+$14.8M
4
EAM
EverPoint Asset Management
Connecticut
+$7.64M
5
CCM
Cadian Capital Management
New York
+$7.29M

Top Sellers

1
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
-$995K
2
PP
PDT Partners
New York
-$458K
3
Deutsche Bank
Deutsche Bank
Germany
-$299K
4
TC
TFS Capital
Pennsylvania
-$188K
5
TG
TLP Group
Illinois
-$164K
Name Holding Trade Value Shares
Change 		Change in
Stake
Neuberger Berman Group
51
Neuberger Berman Group
New York
$311K +$332K +20,000 New
SCM
52
Sterling Capital Management
North Carolina
$270K +$88.9K +5,352 +45%
Wells Fargo
53
Wells Fargo
California
$268K +$139K +8,348 +94%
MWP
54
MYCIO Wealth Partners
Pennsylvania
$265K – – –
Barclays
55
Barclays
United Kingdom
$258K +$88.1K +5,299 +47%
AllianceBernstein
56
AllianceBernstein
Tennessee
$243K +$71.5K +4,300 +38%
RhumbLine Advisers
57
RhumbLine Advisers
Massachusetts
$235K +$47.5K +2,861 +23%
New York State Common Retirement Fund
58
New York State Common Retirement Fund
New York
$215K – – –
CS
59
Credit Suisse
Switzerland
$194K +$10.1K +610 +5%
Manulife (Manufacturers Life Insurance)
60
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$173K +$59.1K +3,555 +47%
PPA
61
Parametric Portfolio Associates
Washington
$171K +$182K +10,956 New
BA
62
BlackRock Advisors
Delaware
$155K +$50.7K +3,050 +44%
SG Americas Securities
63
SG Americas Securities
New York
$154K +$164K +9,891 New
Bank of Montreal
64
Bank of Montreal
Ontario, Canada
$143K +$140K +8,453 +4,227%
NFA
65
Nationwide Fund Advisors
Ohio
$135K – – –
Macquarie Group
66
Macquarie Group
Australia
$127K +$136K +8,176 New
AIG
67
American International Group
New York
$121K -$349 -21 -0.3%
IA
68
IFP Advisors
Florida
$97K +$3.32K +200 +3%
Bank of America
69
Bank of America
North Carolina
$82K +$76.2K +4,584 +647%
Legal & General Group
70
Legal & General Group
United Kingdom
$75K +$38.7K +2,328 +96%
Group One Trading
71
Group One Trading
Illinois
$61K +$64.8K +3,900 New
UBS Group
72
UBS Group
Switzerland
$56K +$2.91K +175 +5%
BG
73
BlackRock Group
United Kingdom
$44K +$47.2K +2,839 New
Citigroup
74
Citigroup
New York
$23K – – –
Canada Life
75
Canada Life
Manitoba, Canada
$22K – – –
1 2
3
4

COLL Hedge Fund Activity: Q4 2016 in Review

88 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Collegium Pharmaceutical (COLL) for Q4 2016, worth a combined $363M — up 19% from $305M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new COLL positions and 3 closed out — a net gain of 17 holders — while 45 added to existing stakes and 8 trimmed.

The largest buyer was Sectoral Asset Management, adding an estimated $23.2M. The largest seller was Massachusetts Financial Services, cutting an estimated $995K.

  • 88 institutional investors held Collegium Pharmaceutical (COLL) as of Q4 2016, up from 71 in Q3 2016.
  • Funds reported $363M of Collegium Pharmaceutical stock for Q4 2016, up 19% quarter-over-quarter.
  • 20 funds opened new Collegium Pharmaceutical positions in Q4 2016 and 3 closed out, a net change of +17 holders.
  • The largest Collegium Pharmaceutical buyer in Q4 2016 was Sectoral Asset Management, an estimated $23.2M added.
  • The largest Collegium Pharmaceutical seller in Q4 2016 was Massachusetts Financial Services, an estimated $995K sold.

Based on aggregated 13F filings for Q4 2016.